Seed VC · USA

Cure Ventures

Active

What they invest in

We work alongside entrepreneurs to impart lessons learned from a proud legacy of landmark labs, breakthrough discoveries, and historic companies. We know people drive life-changing therapeutics – not just capital.

Who they back

DeepTechHealthtechBiotechSeed

Business models

biotech_therapeutics, deeptech_ip, platform

Customer segments

Patients, Researchers

Geography

US

Recent investments

  • XenImmune
  • Tasca Therapeutics
  • Aevum

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

10 partners on file at Cure Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Cure Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Cure Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Apr 2023
New fund raised (SEC Form D)
Dec 2025
Portfolio last checked
Oct 6, 2026
Website
curevc.com ↗

Other firms investing in DeepTech

See all investors

Is Cure Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Cure Ventures is one of them, and we'll tell you exactly where they sit in your top 100.